Skip to content

Teach-Back Educational Method On Diabetes Knowledge Level

The Impact Of Teach-Back Educational Method On Diabetes Knowledge Level And Clinical Parameters In Type 2 Diabetes Patients Undergoing Insulin Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04509856
Enrollment
130
Registered
2020-08-12
Start date
2019-04-01
Completion date
2019-07-31
Last updated
2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Empowerment

Keywords

diabetes, education, teach-back

Brief summary

It was aimed to research the effect of teach-back educational method on diabetes knowledge level and clinical parameters in type 2 diabetes patients undergoing insulin therapy. This is a randomized-controlled trial. Teach-back method will used for intervention group, routin diabetes education will used for control group. The primary outcome is diabetes knowledge levels (DKL), and secondary outcome is clinical patameters (fasting blood glucose, HbA1c, blood pressure). DKL and clinical parameters will measured and compared between two groups before and three months after the interventions.

Interventions

BEHAVIORALTeach-back educational method

In the teach-back method, after teaching new information to the patient, the patients were asked to explain that new information in their own words. Then the patients' knowledge and the adequateness of their explanations were determined. The patient should repeat the instructions in their own words. In this way, the healthcare professional can evaluate how the patient understands the information. If the patient repeated the information correctly, the teach-back phase for that information was completed, and progression for new information was resumed. However, if there was a deficiency or error in the information, it was corrected and repeated by the healthcare professional.

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* To have Type 2 Diabetes * To be over 18 years old * Not have any barriers in understanding and speaking Turkish * Who started insulin treatment for the first time

Exclusion criteria

* Patients with a diagnosis of dementia * To have vision or hearing loss

Design outcomes

Primary

MeasureTime frameDescription
Diabetes knowledge level (DKL)3 monthsThe DKL will be measured through a self-structured questionnaire containing 11 items. The questionnaire contains three answers: yes, no, or I do not know. The right answer will be accepted as two points, the wrong answer as zero points, and the I do not know answer will be accepted as one point. The total scores ranges from 0-22. Higher scores of the questionnaire indicates that the higher DKL.

Secondary

MeasureTime frameDescription
Fasting blood glucose3 monthsFasting blood glucose in mg/dl
HbA1c3 monthsHbA1c in %
Blood pressure3 monthsBlood pressure in mmHG

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026